Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

 
 

LIGAND PHARMACEUTICALS INC (LGND) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $151.56 Metrics
OS: 17.4 M 4 % ROE
Market cap: $2.63 B 8 % ROIC
Net cash: $219 M $12.62 per share
EV: $2.41 B

 
TTM Valuation
EBITDA
EBIT ($7.2) M
EPS $1.71 88.4 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17Dec-05-17
Revenues196.2277.1186.4120.3251.5251.5141.188.7
            Revenue growth-29.2%48.7%55.0%-52.2%78.2%183.5%29.5% 
Cost of goods sold123.147.223.416.915.850.012.144.4
Gross profit73.1230.0163.0103.4235.7201.5129.044.3
            Gross margin37.2%83.0%87.4%86.0%93.7%80.1%91.4%50.0%
Selling, general and administrative        
Research and development 69.059.455.927.9 26.9 
General and administrative70.157.564.441.937.737.728.728.7
EBITA3.0126.149.2824.0179.5163.780.268.1
            EBITA margin1.5%45.5%26.4%685.0%71.4%65.1%56.8%76.8%
Amortization of intangibles 47.223.416.915.8 12.1 
EBIT3.078.925.8807.1163.7163.768.168.1
            EBIT margin1.5%28.5%13.9%671.0%65.1%65.1%48.2%76.8%
Pre-tax income36.047.3-10.5796.6173.3173.357.257.2
Income taxes41.2-9.8-7.6167.330.00.044.7-44.7
            Tax rate114.5% 71.7%21.0%17.3%0.0%78.1% 
Earnings from continuing ops-5.257.1-3.0629.3143.3 12.6 
Earnings from discontinued ops-28.1       
Net income-33.457.1-3.0629.3143.30.012.60.0
            Net margin-17.0%20.6%-1.6%523.2%57.0%0.0%8.9%0.0%
 
Diluted EPS($0.31)$3.31($0.18)$31.85$5.96 $0.53 
Shares outstanding (diluted)16.817.216.219.824.1 23.5 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy